P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE)
National Institutes of Health
Description
This grant opportunity provides funding for P50 SPORE grants aimed at supporting advanced research projects that focus on improving the prevention, early detection, diagnosis, and treatment of specific types of cancer or closely related cancers. The funded research must be translational, based on studies of human biology using cellular, molecular, structural, biochemical, or genetic methods, and must aim to achieve practical human results within the grant's timeframe.
The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. The research supported through…
Source
Grant ID
PAR-23-284
Agency
National Institutes of Health
Subcategory/Subagency
National Cancer Institute
Program
SBIR
Key Dates
Opportunity Released
September 22, 2023
Open for Submission
September 22, 2023
Submission Deadline
September 25, 2026
Application Window Closes
September 25, 2026
Eligibility
The following categories of applicants are invited to apply:
- Public/State-Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) status (other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) status (other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments (general)
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
Similar opportunities
- Exploratory Research Projects for Innovative Molecular Analysis Technologies in Cancer Research
National Institutes of Health
- Exploratory/Developmental Research Grant Program (R21)
National Institutes of Health
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
National Institutes of Health
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Department of Health and Human Services